$VTGN 👀 🔹️ Yesterday's multibillion-dollar Eli Lilly acquisition of AtaiBeckley $ATAI shows Big Pharma is willing to pay a premium for innovative intranasal C

$VTGN 👀 🔹️ Yesterday's multibillion-dollar Eli Lilly acquisition of AtaiBeckley $ATAI shows Big Pharma is willing to pay a premium for innovative intranasal CNS therapies. 🔹️ Vistagen's pipeline is also built around a proprietary intranasal pherine platform targeting brain neurocircuitry with rap…